Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
3 hedge funds and large institutions have $62K invested in Zosano Pharma Corporation in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 27 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
90% less funds holding
Funds holding: 30 → 3 (-27)
98% less capital invested
Capital invested by funds: $2.97M → $62K (-$2.91M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CDIA
Capital Directions Investment Advisors
Atlanta,
Georgia
|
+$236 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.16M |
| 2 |
BlackRock
New York
|
-$462K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$203K |
| 4 |
State Street
Boston,
Massachusetts
|
-$98K |
| 5 |
Renaissance Technologies
New York
|
-$56K |
ZSAN Hedge Fund Activity: Q2 2022 in Review
3 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2022, worth a combined $62K — down 98% from $2.97M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of ZSAN and 0 opened new positions — a net loss of 27 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Capital Directions Investment Advisors, adding an estimated $236. The largest seller was Vanguard Group, exiting entirely with an estimated $1.16M sold.
- 3 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2022, down from 30 in Q1 2022.
- Funds reported $62K of Zosano Pharma Corporation stock for Q2 2022, down 98% quarter-over-quarter.
- 0 funds opened new Zosano Pharma Corporation positions in Q2 2022 and 27 closed out, a net change of -27 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2022 was Capital Directions Investment Advisors, an estimated $236 added.
- The largest Zosano Pharma Corporation seller in Q2 2022 was Vanguard Group, an estimated $1.16M sold.
Based on aggregated 13F filings for Q2 2022.